2 hours Viking Therapeutics (NASDAQ:VKTX) Receives Buy Rating from HC Wainwright MarketBeat
HC Wainwright reiterated a “buy” rating and set a $90.00 target price on shares of Viking Therapeutics in a research note on Wednesday.
HC Wainwright reiterated a “buy” rating and set a $90.00 target price on shares of Viking Therapeutics in a research note on Wednesday.